Chinese medical journal
-
Chinese medical journal · Nov 2018
Randomized Controlled TrialEfficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis.
Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This study assessed the efficacy and safety of tofacitinib in Chinese patients with RA enrolled in Phase 3 and long-term extension (LTE) studies. ⋯ NCT00856544 and NCT00413699.